PRAME Expression in Melanocytic Tumors (Q90468917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

title

PRAME Expression in Melanocytic Tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

2

Achim A Jungbluth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Cecilia Lezcano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

Kishwer S Nehal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

Travis J Hollmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

Klaus J Busam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

publication date

1 November 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

The American Journal of Surgical Pathology

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

1456-1465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

14 April 2020

cites work

1 reference

12 December 2020

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

1 reference

12 December 2020

The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome

1 reference

12 December 2020

Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia

1 reference

12 December 2020

Expression of MCSP and PRAME in conjunctival melanoma.

1 reference

12 December 2020

The cancer testis antigen PRAME as a biomarker for solid tumor cancer management

1 reference

12 December 2020

Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma

1 reference

12 December 2020

PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

1 reference

12 December 2020

PRAME expression and promoter hypomethylation in epithelial ovarian cancer

1 reference

12 December 2020

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.

1 reference

12 December 2020

Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.

1 reference

12 December 2020

Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study.

1 reference

12 December 2020

Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers

1 reference

12 December 2020

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

1 reference

12 December 2020

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study.

1 reference

12 December 2020

Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.

1 reference

12 December 2020

Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes

1 reference

12 December 2020

Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy

1 reference

12 December 2020

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.

1 reference

12 December 2020

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.

1 reference

12 December 2020

10.1097/PAS.0000000000001134

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30045064 AND SRC:MED&resulttype=core&format=json

14 April 2020

PubMed publication ID

30045064

1 reference